Capabilities · Analytical & stability services

Analytical method development

A proposed service scope for analytical evaluation, connecting initial methodology design, product-specific parameters and the establishment of suitable test procedures.

PlannedCatalogue scope

Illustrative unbranded autosampler vial detail.
Illustrative unbranded autosampler vial detail. It does not depict Luang Pharma's project, products or installed equipment.

Service statusPlanned

Planned.

Technical boundaries and readiness need confirmation before an activity could be presented as available.

Basis · Catalogue scope

Status
PlannedNo available service asserted
Source-plan relationship
Catalogue scopeProposed catalogue expansion
Readiness
Not establishedProduct and process evidence needed
Facility roadmap
First commercial batch target Q1 2028 · indicativeNot a service date

01 · Proposed service scope

Start with the product and its container.

Analytical method development is presented as a planned service domain. The exact product, material characteristics and intended analytical technique would define its scope and requirements.

The initial formulation-and-filling plan identifies specific injectable presentation families. Analytical method development represents a proposed expansion in the catalogue, requiring scope confirmation before any such service could be offered.

Method development and formal method validation are distinct technical stages. Initial evaluation of a procedure does not establish its suitability for formal release testing or stability assessment.

Catalogue boundary

A planned catalogue for scoped evaluation. Inclusion does not establish installed, qualified, licensed or available capability.

02 · Presentation families

Match the route to the format.

Planned formats and their source relationship
FormatPlanning noteBasisStatus
Drug substance methodsSmall-molecule active ingredientsProposed evaluation for active ingredients and bulk biological materials.Catalogue scopePlanned
Finished product methodsRaw-material & finished-product testingDevelopment of analytical procedures for the proposed final dosage form.Catalogue scopePlanned
Excipient and material methodsMethodology evaluation for inputs lacking established pharmacopoeial monographs.Catalogue scopePlanned

03 · Process scope for discussion

Make the sequence and its evidence visible.

01 · Process stage

Planned

Analytical objective definition

Define the intended purpose, target analyte and proposed matrix for the required test procedure.

02 · Process stage

Planned

Methodology and technique selection

Consider appropriate analytical techniques based on the relevant chemical or biological material characteristics.

03 · Process stage

Planned

Initial parameter evaluation

Assess fundamental conditions, including sample preparation steps, operating parameters and preliminary detection limits.

04 · Process stage

Planned

Specificity and interference assessment

Evaluate the ability of the proposed procedure to discriminate the target analyte from potential matrix components.

05 · Process stage

Planned

Method optimisation

Refine the analytical conditions to establish a reliable procedure for the intended sample type.

06 · Process stage

Planned

Pre-validation documentation

Draft the proposed method procedure and summarise the development data for subsequent formal evaluation.

Illustrative sequence

This is a technical discussion structure, not an operating procedure, approved process flow or representation of installed equipment.

04 · Supporting services

No service stands alone.

01PlannedCatalogue scope

Method transfer & validation

Transfer protocols, method performance and agreed acceptance criteria.

Explore proposed scope

02PlannedCatalogue scope

Stability studies

Study design, conditions, sampling and product-container relevance.

Explore proposed scope

03PlannedCatalogue scope

Preformulation & formulation development

Material properties, formulation options and product-specific development questions.

Explore proposed scope

05 · Readiness questions

A service claim needs a defined evidence base.

Material characteristics
Exact physical, chemical or biological properties of the intended analyte and matrix.
Facility and systems
Relevant installed analytical equipment, qualification status and an approved evaluation scope.
Method requirements
Defined analytical objectives, required sensitivity and the intended regulatory context.
Quality responsibilities
Controlled documentation structures, data integrity controls and review frameworks.
Regulatory context
Applicable analytical guidance and pharmacopoeial references for the proposed technique.
Technical agreement
Responsibilities, intellectual property controls and boundaries for any proposed development work.

06 · Practical questions

Before a technical discussion.

Is this service currently available?

No. The service is Planned. This page is a scope proposal and does not establish an operating analytical method development service.

Which analytical techniques are included in this proposed scope?

The catalogue lists method development as a broad domain. Any specific technique, such as chromatography or spectroscopy, would require separate technical discussion and equipment confirmation.

What information helps define the question?

Identify the target analyte, material matrix, development stage, intended test purpose and the technical question. Confidential data should only be shared through an agreed route.

Is there a service launch quarter?

No. No service-specific quarter is established. The project-wide indicative milestones do not commit any individual service to a start date.

Does a technical discussion establish supply?

No. Feasibility, equipment requirements, permissions, analytical evidence and any formal agreement would need to be established before a service commitment.

Back to capabilities

Professional enquiries

Discuss a defined question.

Describe the presentation, development question and destination relevant to the proposed scope. Do not infer service availability from this planning page.

Contact Luang Pharma